Clinical Trials Browser

Recruiting × Lymphoma, T-Cell × duvelisib × Clear all

NCT07293403 2026-06-02

Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas

Phase 2 Recruiting

Lymphoma, T-Cell

NCT05010005 2026-04-09

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, Prolymphocytic, T-Cell, Lymphoma, T-Cell, Leukemia, Large Granular Lymphocytic